05-Apr-2005 - Takeda Pharmaceutical Company Limited

Takeda to Transfer its Life-environmental Business to Osaka Gas

Osaka Gas Co., Ltd. and Takeda Pharmaceutical Company Limited jointly announced the transfer of shares of Takeda's five subsidiaries and affiliates engaged in life-environmental business to Osaka Gas Chemicals Co., Ltd. , a subsidiary of Osaka Gas. Such five companies include Japan EnviroChemicals, Ltd., a wholly owned subsidiary of Takeda.

Osaka Gas is committed to increase its corporate value by enhancing the non-energy businesses expected to grow in the future. As one of such efforts, Osaka Gas Chemicals aims to expand its carbon-based business such as activated carbon, electrode materials and fine materials, all of which are based on the technologies accumulated during the time when coal was the main resource for Osaka Gas's gas production.

Takeda is aiming to become an R&D oriented, world-class pharmaceutical company, and to that effect, it has been promoting independence of its non-pharmaceutical businesses in order to concentrate management resources into pharmaceutical business. As one of its movements, the life-environmental business of Takeda became an independent subsidiary, Japan EnviroChemicals in April 2003 as first step, and Takeda has been seeking the optimal business model to find Osaka Gas Chemicals as the most appropriate partner to which the business will be transferred as announced.

One of the Osaka Gas Chemicals' strengths is that it manufactures and sells consumer goods such as household water purifiers using highly adsorptive activated carbon fibers, while Japan EnviroChemicals has top market share in products such as granulated/powdered activated carbon, and wood preservatives. The synergy effect by consolidation of technology and know-how of Osaka Gas Chemicals and Japan EnviroChemicals including other four companies is highly expected to contribute to expansion of the businesses leveraged on the further enriched product-line and wider range of targeted customers.

Facts, background information, dossiers
  • Osaka Gas
  • Japan
  • Takeda
More about Takeda Pharma
  • News

    Hitachi and Takeda to Establish "Hitachi Inspharma, Ltd." for Information System Support for Takeda

    Hitachi, Ltd. and Takeda Pharmaceutical Company Limited announced that both parties established a joint venture "Hitachi Inspharma, Ltd." for information system support in which Hitachi and Takeda owns 66% and 34% shares respectively. The newly established company will start its operation ... more

    Takeda to Acquire Syrrx

    Takeda Pharmaceutical Company Limited announced that Takeda and Syrrx Inc. agreed on February 5, 2005 (PST) to merge Syrrx, Inc. into the Takeda Group. The merger is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act and is subject to the satisfaction of other custo ... more

More about Osaka Gas
  • News

    Chevron Secures Multiple Sales Agreements for Gorgon LNG

    Chevron Corporation announced that Australian subsidiaries of Chevron have signed three binding long-term Sales and Purchase Agreements (SPAs) for Chevron's share of liquefied natural gas (LNG) from the Gorgon project. The agreements are for a total supply of nearly 3 million tons per annum ... more